Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | DNMT1 | P26358 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 4/20 | 0.41 |
| ▸ | CA1 | P00915 | 4/20 | 0.41 |
| ▸ | CA2 | P00918 | 4/20 | 0.41 |
| ▸ | CA9 | Q16790 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15028262 | 0.90 | MAPT (0.47) | DNMT1KDM4EMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL21889361 | 0.89 | ALDH1A1 (0.44) | DNMT1CA12CA1CA2CA9 | |
| SCHEMBL29773784 | 0.83 | ALDH1A1 (0.56) | DNMT1KDM4EMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL75606 | 0.83 | ALDH1A1 (0.56) | DNMT1KDM4EMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL10304455 | 0.83 | ALDH1A1 (0.54) | DNMT1CA12CA1CA2CA9 | |
| SCHEMBL10015037 | 0.81 | ALDH1A1 (0.41) | DNMT1CA12CA1CA2CA9 | |
| SCHEMBL22727693 | 0.81 | MAPT (0.40) | KDM4EMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL23349028 | 0.81 | CES1 (0.58) | PTPN1DNMT1CA12CA1CA2 | |
| SCHEMBL31619746 | 0.81 | CES1 (0.58) | PTPN1DNMT1CA12CA1CA2 | |
| SCHEMBL75348 | 0.81 | CYP1B1 (0.51) | KDM4EMAPTALDH1A1PABPC1P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8963813-B2 | Organic compound and organic light emitting device having the same | CANON KABUSHIKI KAISHA (JP) | 2015-02-24 | — | — | US | disclosed |
| US-8963813-B2 | Organic compound and organic light emitting device having the same | CANON KABUSHIKI KAISHA (JP) | 2015-02-24 | — | — | US | disclosed |
| US-20140231787-A1 | WHITE ORGANIC EL ELEMENT AND ILLUMINATING APPARATUS AND DISPLAY APPARATUS USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2014-08-21 | — | — | US | disclosed |
| US-20140231787-A1 | WHITE ORGANIC EL ELEMENT AND ILLUMINATING APPARATUS AND DISPLAY APPARATUS USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2014-08-21 | — | — | US | disclosed |
| US-20130033416-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2013-02-07 | — | — | US | disclosed |
| US-20130033416-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2013-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130033416-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME | TRPA1, OCIAD1, BMP2 | PTPN1 4543/4885DNMT1 642/4885CA12 1846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.